Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Current and emerging concepts in tumour metastasis.

Coghlin C, Murray GI.

J Pathol. 2010 Sep;222(1):1-15. doi: 10.1002/path.2727. Review.

PMID:
20681009
2.

New results from the use of bisphosphonates in cancer patients.

Coleman R, Gnant M.

Curr Opin Support Palliat Care. 2009 Sep;3(3):213-8. doi: 10.1097/SPC.0b013e32832f4149. Review.

PMID:
19561507
3.

Bone marrow cells in the 'pre-metastatic niche': within bone and beyond.

Kaplan RN, Psaila B, Lyden D.

Cancer Metastasis Rev. 2006 Dec;25(4):521-9. Review.

PMID:
17186383
4.

Cancer stem cells as new therapeutic target to prevent tumour progression and metastasis.

Mueller MT, Hermann PC, Heeschen C.

Front Biosci (Elite Ed). 2010 Jan 1;2:602-13. Review.

PMID:
20036905
5.

Host genetics and tumour metastasis.

Hunter KW.

Br J Cancer. 2004 Feb 23;90(4):752-5. Review.

6.

Management of bone metastases in cancer: a review.

Selvaggi G, Scagliotti GV.

Crit Rev Oncol Hematol. 2005 Dec;56(3):365-78. Epub 2005 Jun 23. Review.

PMID:
15978828
7.

The importance of blood cell-vessel wall interactions in tumour metastasis.

Poggi A, Stella M, Donati MB.

Baillieres Clin Haematol. 1993 Sep;6(3):731-52. Review.

PMID:
8025349
8.

Priming the 'soil' for breast cancer metastasis: the pre-metastatic niche.

Psaila B, Kaplan RN, Port ER, Lyden D.

Breast Dis. 2006-2007;26:65-74. Review.

PMID:
17473366
9.

Current concepts of tumour metastasis.

Barbour A, Gotley DC.

Ann Acad Med Singapore. 2003 Mar;32(2):176-84. Review.

PMID:
12772520
10.

Cancer stem cells: implications for the progression and treatment of metastatic disease.

Croker AK, Allan AL.

J Cell Mol Med. 2008 Apr;12(2):374-90. doi: 10.1111/j.1582-4934.2007.00211.x. Epub 2007 Dec 20. Review.

11.

The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cells.

Koh BI, Kang Y.

EMBO Rep. 2012 May;13(5):412-22. doi: 10.1038/embor.2012.41. Review.

12.

Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters.

Entschladen F, Drell TL 4th, Lang K, Joseph J, Zaenker KS.

Lancet Oncol. 2004 Apr;5(4):254-8. Review.

PMID:
15050959
13.

Bisphosphonates and metastatic bone disease.

Barni S, Mandalà M, Cazzaniga M, Cabiddu M, Cremonesi M.

Ann Oncol. 2006 Mar;17 Suppl 2:ii91-95. Review. No abstract available.

PMID:
16608996
14.

Bone metastasis and the metastatic niche.

Ren G, Esposito M, Kang Y.

J Mol Med (Berl). 2015 Nov;93(11):1203-12. doi: 10.1007/s00109-015-1329-4. Epub 2015 Aug 15. Review.

15.

Concepts of metastasis in flux: the stromal progression model.

Sleeman JP, Christofori G, Fodde R, Collard JG, Berx G, Decraene C, Rüegg C.

Semin Cancer Biol. 2012 Jun;22(3):174-86. doi: 10.1016/j.semcancer.2012.02.007. Epub 2012 Feb 21. Review.

16.

Microenvironment in metastasis: roadblocks and supportive niches.

Pein M, Oskarsson T.

Am J Physiol Cell Physiol. 2015 Nov 15;309(10):C627-38. doi: 10.1152/ajpcell.00145.2015. Epub 2015 Sep 16. Review.

17.

[Treatment of bone metastases with bisphosphonates].

Gremaud M, Delouche D, Monnerat C.

Rev Med Suisse. 2006 Aug 9;2(75):1861-6. Review. French.

PMID:
16948423
18.

Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T.

Nat Rev Cancer. 2005 Sep;5(9):744-9. Review.

PMID:
16148886
19.

On the horizon: can bisphosphonates prevent bone metastases?

Coleman R.

Breast. 2007 Dec;16 Suppl 3:S21-7. Epub 2007 Nov 7. Review.

PMID:
17988867
20.

Host and tumour factors in cancer metastasis.

Fidler IJ.

Eur J Clin Invest. 1990 Oct;20(5):481-6. Review.

PMID:
2124977

Supplemental Content

Support Center